Synthetic cancer cohort (RUNX1, AML) - ICDG use case
Data and Resources
This dataset has no data
Additional Info
| Field | Value |
|---|---|
| Title | Synthetic cancer cohort (RUNX1, AML) - ICDG use case |
| Description | SYNTHETIC somatic oncology use case. Tumour/normal pairs on the open 1000G Phase 3 chr21 backbone with synthetic somatic variants modelled on RUNX1 (acute myeloid leukemia). OPEN access. Discoverable in Beacon v2 (count) and streamable by genomic range via GA4GH htsget. Beacon dataset id ICDG_synthetic_cancer_RUNX1_chr21; htsget id icdg-synthetic-cancer-chr21. No patient data. See docs/use-cases-cancer-rare-disease.md. |
| Keywords | |
| Contact points | |
| Publisher | |
| Creator | |
| Landing page | |
| Release date | |
| Modification date | |
| In Series | |
| Version | |
| Version notes | |
| Dataset status | |
| Identifier | ICDG_synthetic_cancer_RUNX1_chr21 |
| Frequency | |
| Provenance | |
| Type | |
| Temporal coverage | |
| Temporal resolution | |
| Spatial coverage | |
| Spatial resolution in meters | |
| Access rights | http://publications.europa.eu/resource/authority/access-right/PUBLIC |
| Other identifier | |
| Theme |
|
| Language | |
| Documentation | |
| Conforms to | |
| Is referenced by | |
| Distribution | |
| Sample | |
| Analytics | |
| Applicable legislation | |
| Has version | |
| Code values | |
| Coding system | |
| Purpose | |
| Health category | |
| Health theme | |
| Legal basis | |
| Minimum typical age | |
| Maximum typical age | |
| Number of records | |
| Number of records for unique individuals. | |
| Personal data | |
| Publisher note | |
| Publisher type | |
| Trusted Data Holder | |
| Population coverage | |
| Retention period | |
| Health data access body | |
| Qualified relation | |
| Was generated by | |
| Qualified attribution | |
| Quality annotations | |
| URI |